Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-21-058071

Chief Medical Officer acquired 5,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Pang Phillip Chief Medical Officer 2021-09-27 Option exercise +5,000 $0.86 $4,275 109,277 D
Derivatives
Pang Phillip Chief Medical Officer 2021-09-27 Option exercise · Employee Stock Option (Right to Buy) −5,000 18,833 D
Loading xslF345X03/doc4.xml…